trial

Benefits Management for People With Psychiatric Disabilities

NCTId NCT01329393
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 99 (actual)
Sponsored by Yale University
Primary completion 2013-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
99 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2010-08
Primary completion
2013-12
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Benefits ManagementIllness Management and Recovery

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
VA Connecticut Healthcare SystemCollaborator

Investigators

1
Marc L. Steinberg, PH.D.Principal Investigator

Sites

1 total
Hartford, United States

Facts & assertions

4 sourced
Enrollment
99
Phase
PHASE1
Primary Completion Date
2013-12
Status
COMPLETED
relationships
The graph out of here
drug
Benefits Management
drug
Illness Management and Recovery
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
VA Connecticut Healthcare System
company
indication
Bipolar Disorder
indication
Schizophrenia
indication
Bipolar Disorder
indication
investigator
Marc L. Steinberg, PH.D.
person